Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 11 résultats.
    • Article de périodique
    Predictors of Benefit in Colorectal Cancer Treated With Cetuximab: Are We Getting "Lost in TranslationAL"? Reply
    Jacobs, Bart[UCL] Piessevaux, Hubert[UCL] De Roock, Wendy[UCL] Biesmans, Bart[UCL] De Schutter, Jef[UCL] Claes, Bart[UCL] Tejpar, Sabine[UCL] (2010) Journal of Clinical Oncology — Vol. 28, no. 11, p. E175-E176 (2010)
    • Communication
    Levels of amphiregulin and epiregulin expression correlate with overall survival in colorectal cancer treated with cetuximab
    De Roock, Wendy[UCL] Piessevaux, Hubert[UCL] Biesmans, Bart[UCL] De Schutter, Jef[UCL] Van Cutsem, Emmanuel[UCL] Tejpar, Sabine[UCL] (2007) Annual Meeting of the EORTC-NCI-ASCO on Molecular Markers in Cancer — Brussels (Belgium)
    • Communication
    High Amphiregulin and Epiregulin expression in K-ras wild type colorectal primaries predicts response and survival benefit after treatment with cetuximab and irinotecan for metastatic disease
    Tejpar, Sabine[UCL] Piessevaux, Hubert[UCL] Humblet, Yves[UCL] De Roock, Wendy[UCL] Biesemans, Bart[UCL] De Schutter, Jef[UCL] Peeters, Marc Celik, Ilhan Van Cutsem, Eric[UCL] (2007) —
    • Article de périodique
    A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy
    Saridaki, Zenia Weidhaas, Joanne B. Lenz, Heinz-Josef Laurent-Puig, Pierre Jacobs, Bart De Schutter, Jef De Roock, Wendy Salzman, David W. Zhang, Wu Yang, Dongyun Pilati, Camilla Bouché, Olivier Piessevaux, Hubert[UCL] Tejpar, Sabine (2014) Clinical Cancer Research — Vol. 20, no. 17, p. 4499-4510 (2014)
    • Article de périodique
    Reply to C. Cremolini et al
    Jacobs, Bart De Roock, Wendy Piessevaux, Hubert[UCL] Biesmans, Bart De Schutter, Jef Claes, Bart Tejpar, Sabine (2010) Journal of Clinical Oncology — Vol. 28, no. 11, p. e175-e176 (2010)
    • Article de périodique
    Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab
    Jacobs, Bart De Roock, Wendy Piessevaux, Hubert[UCL] Van Oirbeek, Robin Biesmans, Bart De Schutter, Jef Fieuws, Steffen Vandesompele, Jo Peeters, Marc Van Laethem, Jean-Luc Humblet, Yves[UCL] Pénault-Llorca, Frédérique De Hertogh, Gert Laurent-Puig, Pierre Van Cutsem, Eric Tejpar, Sabine (2009) Journal of Clinical Oncology — Vol. 27, no. 30, p. 5068-5074 (2009)
    • Article de périodique
    KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab
    De Roock, Wendy Piessevaux, Hubert[UCL] De Schutter, Jef Janssens, Marc De Hertogh, Gert Personeni, Nicola Biesmans, Bart Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Annals of Oncology — Vol. 19, no. 3, p. 508-515 (2008)
    • Article de périodique
    Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With Cetuximab
    De Roock, Wendy Piessevaux, Hubert[UCL] Jonker, Derek J. Di Nicolantonio, Federica Sartore-Bianchi, Andrea Tu, Dongsheng Siena, Salvatore Lamba, Simona Arena, Sabrina Frattini, Milo Van Cutsem, Eric[UCL] O'Callaghan, Chris J. Khambata-Ford, Shirin Zalcberg, John R. Simes, John Karapetis, Christos S. Bardelli, Alberto Tejpar, Sabine[UCL] (2010) JAMA : the journal of the American Medical Association — Vol. 304, no. 16, p. 1812-20 (2010)
    • Article de périodique
    Clinical usefulness of EGFR gene copy number as a predictive marker in colorectal cancer patients treated with cetuximab : A fluorescent in situ hybridization study
    Personeni, Nicola Fieuws, Steffen Piessevaux, Hubert[UCL] De Hertogh, Gert De Schutter, Jef Biesmans, Bart De Roock, Wendy Capoen, An Debiec-Rychter, Maria Van Laethem, Jean-Luc Peeters, Marc Humblet, Yves[UCL] Van Cutsem, Eric Tejpar, Sabine (2008) Clinical Cancer Research — Vol. 14, no. 18, p. 5869-5876 (2008)
    • Article de périodique
    Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
    De Roock, Wendy[UCL] Piessevaux, Hubert[UCL] Claes, Bart[UCL] De Schutter, Jef[UCL] Biesmans, Bart[UCL] Van Cutsem, Eric[UCL] Lambrechts, Diether[UCL] Tejpar, Sabine[UCL] (2010) The Lancet Oncology — Vol. 11, no. 8, p. 753-762 (2010)
    • Article de périodique
    Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial).
    Piessevaux, Hubert[UCL] Buyse, M. De Roock, Wendy[UCL] Prenen, H Schlichting, M Van Cutsem, Emmanuel[UCL] Tejpar, Sabine[UCL] (2009) Annals of oncology : official journal of the European Society for Medical Oncology / ESMO — Vol. 20, no. 8, p. 1375-82 (2009)